| Synonyms: | |
| Status: | Approved (2023) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | ODU3ZAZ94J |
| InChI Key | JJVAPHYEOZSKJZ-JGCGQSQUSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C36H46N8O3 |
| Molecular Weight | 638.82 |
| AlogP | 3.45 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 120.67 |
| Molecular species | BASE |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 47.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 24000 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 10-22 | |
|
Membrane receptor
Family B G protein-coupled receptor
Peptide receptor (family B GPCR)
Calcitonin-like receptor
Calcitonin gene-related peptide receptor
|
- | - | - | 0 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Migraine Disorders | 3 | D008881 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2397415 |
| DrugBank | DB15688 |
| FDA SRS | ODU3ZAZ94J |
| SureChEMBL | SCHEMBL107428 |
| ZINC | ZINC000096271995 |